Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
RXST

RxSight (RXST) stock: insider trades, news & valuation

Heavy selling
Close · Oct 9, 2026 $4.81 -0.8% on the day -40.7% over 12 months 52-week range $4.59 – $13.09

Share price and insider trades

RXST closeInsider buyInsider sale
258101215NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $117,951 on 2026-09-02 · Eric Weinberg, Ilya Goldshleger, Mark Wilterding, Ronald M Md Kurtz
Bought, 12 months$0
Sold, 12 months$118K
Insiders buying0
Insiders selling4

RxSight insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $118K of RXST stock on the open market.

RXST insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q3 2026: $118K sold (4 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$118K4

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.8×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 RxSight, Inc. insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $118K. 0 of 4 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 2SEC Mark WilterdingCFO Sell 7,76525,049 held (−24%) $6.96 $54K -30.9% —
Sep 2SEC Ronald M Md KurtzChief Medical Officer Sell 5,10071,775 held (−7%) $6.96 $35K -30.9% —
Sep 2SEC Ilya GoldshlegerCOO Sell 2,04181,509 held (−2%) $6.96 $14K -30.9% —
Sep 2SEC Eric WeinbergSee Remarks Sell 2,041200,348 held (−1%) $6.96 $14K -30.9% —

Insiders at RxSight, Inc.

InsiderBoughtSoldLast filingScore
Mark WilterdingCFO — $54K Sep 2, 2026 —
Ronald M Md KurtzChief Medical Officer — $35K Sep 2, 2026 —
Ilya GoldshlegerCOO — $14K Sep 2, 2026 —
Eric WeinbergSee Remarks — $14K Sep 2, 2026 —

RXST stock: common questions

Are RxSight, Inc. insiders buying RXST stock?

In the past 12 months, 0 insiders reported open-market purchases of RXST worth $0.

Are RxSight, Inc. insiders selling RXST stock?

4 insiders reported sales worth $118K over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is RXST's 52-week range?

Over the past year RXST has traded between $4.59 and $13.09. It last closed at $4.81 on Oct 9, 2026.